comparemela.com

Latest Breaking News On - Integragen onco - Page 1 : comparemela.com

Global NGS Oncology Market Report 2022-2027: Featuring Key Players Bio-Rad Laboratories, Oxford Nanopore Technologies, Pillar Biosciences & Other

/PRNewswire/ The "NGS Oncology Market - A Global and Regional Analysis: Focus on Offering, Sequencing Technology, Workflow, Application, End User, and.

United statesIntegragen oncoPacific biosciencesLaura woodAgilent technologies incBiotechnology companiesPerkinelmer incCalifornia incInvitae corporationFulgent genetics incTakara bio incPillar biosciences incRoche ltdOffice hours callBiodesix incE st office hours call

Global NGS Oncology Market Report 2022-2032: Increasing

Dublin, July 13, 2022 (GLOBE NEWSWIRE) The "NGS Oncology Market - A Global and Regional Analysis: Focus on Offering, Sequencing Technology, Workflow,.

United statesIntegragen oncoPacific biosciencesAgilent technologies incBiotechnology companiesPerkinelmer incCalifornia incInvitae corporationFulgent genetics incTakara bio incPillar biosciences incRoche ltdBiodesix incBio rad laboratories incClinical research organizations crosIllumina inc

BIS Research Study Highlights the Global NGS Oncology Market to Reach $51 78 Billion by 2032

/PRNewswire/ The global NGS oncology market is projected to reach $51.78 billion in terms of revenue by 2032, at a CAGR of 12.04%, suggests the premium.

United statesNitish kumar singhIntegragen oncoPacific biosciencesAgilent technologies incPerkinelmer incCalifornia incInvitae corporationDigital healthFulgent genetics incTakara bio incInformation technologyPillar biosciences incResearch incRoche ltdBiodesix inc

vimarsana © 2020. All Rights Reserved.